2004Henan yixue yanjiuRequires access

Effects of treating uricacidemia by losartan in patients with hypertension associated hyperuricemia

Sun Hong-fang

Open publisher page 0 citations

Abstract

Objective: To study the effects of by losartan in treating patients with hypertension associated with hyperuricemia.Methods: 96 patients with hypertension and were divided into two groups by random (group 1∶50cases, group2∶46cases). Group 1 included patients only taking.Group 2 included patients taking losartan combined other antihypertensive drugs including hydrochlorothiazide. 40cases patients taking captopril was control group. Observed the change of uricacidemia, uricacid in urine and urinary protein of two groups after treatment for 3 days, 1 week, 2 weeks and 4 weeks.Results: Uricacidemia had apparently reduced after losartan treatment for 3 days and the outage of 24 h uricacid had apparently increased with the outage of 24 h urnary protein decreasing.Conclusion: Losartan can be used for underpressure and treating uricacidemia and protection of kidneys.

About this research paper

What this paper is about

Objective: To study the effects of by losartan in treating patients with hypertension associated with hyperuricemia.Methods: 96 patients with hypertension and were divided into two groups by random (group 1∶50cases, group2∶46cases). Group 1 included patients only taking.Group 2 included patients taking losartan combined other antihypertensive drugs including hydrochlorothiazide. 40cases patients taking captopril was control group. Observed the change of uricacidemia, uricacid in urine and urinary protein of two groups after treatment for 3 days, 1 week, 2 weeks and 4 weeks.Results: Uricacidemia had apparently reduced after losartan treatment for 3 days and the outage of 24 h uricacid had apparently increased with the outage of 24 h urnary protein decreasing.Conclusion: Losartan can be used for underpressure and treating uricacidemia and protection of kidneys.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the effects of by losartan in treating patients with hypertension associated with hyperuricemia.Methods: 96 patients with hypertension and were divided into two groups by random (group 1∶50cases, group2∶46cases). Group 1 included patients only taking.Group 2 included patients taking losartan combined other antihypertensive drugs including hydrochlorothiazide. 40cases patients taking captopril was control group. Observed the change of uricacidemia, uricacid in urine and urinary protein of two groups after treatment for 3 days, 1 week, 2 weeks and 4 weeks.Results: Uricacidemia had apparently reduced after losartan treatment for 3 days and the outage of 24 h uricacid had apparently increased with the outage of 24 h urnary protein decreasing.Conclusion: Losartan can be used for underpressure and treating uricacidemia and protection of kidneys.

Key concepts: Losartan, Hyperuricemia, Medicine, Hydrochlorothiazide, Captopril, Urology, Internal medicine, Urine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of treating uricacidemia by losartan in patients with hypertension associated hyperuricemia — Research Paper | ScholarLens